← Xeris Biopharma Holdings, Inc. XERS
Market Price
$8.59
Market Cap
$1.44B
P/E Ratio
N/A
Revenue (FY 2025)
↑43.7% YoY
$291.85M
3-Yr CAGR: 38.3%
Net Income
↑101.0% YoY
$554.00K
Net Margin: 0.2%
Free Cash Flow
↑173.8% YoY
$27.93M
FCF Yield: 1.94%
EPS (Diluted)
↑100.0% YoY
N/A
Basic: N/A
Return on Equity
Efficiency
4.0%
ROA: 0.2%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (XERS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2020 | $20.2M | — | $9.5M | $-91.1M | — | $-2.14 | — | $-80.6M | $-80.9M | — |
| FY 2021 | $49.3M | +144.5% | $42.1M | $-122.7M | -34.7% | $-1.55 | +27.6% | $-95.5M | $-96.6M | -19.4% |
| FY 2022 | $110.2M | +123.7% | $94.9M | $-94.7M | +22.9% | $-0.70 | +54.8% | $-102.9M | $-103.4M | -7.0% |
| FY 2023 | $163.9M | +48.7% | $137.3M | $-62.3M | +34.2% | $-0.45 | +35.7% | $-47.0M | $-49.3M | +52.3% |
| FY 2024 | $203.1M | +23.9% | $172.6M | $-54.8M | +11.9% | $-0.37 | +17.8% | $-37.0M | $-37.8M | +23.2% |
| FY 2025 | $291.8M | +43.7% | $262.8M | $0.6M | +101.0% | — | +100.0% | $28.6M | $27.9M | +173.8% |
Valuation
Market Price
$8.59
Market Cap
$1.44B
Enterprise Value
$1.55B
P/E Ratio
N/A
P/B Ratio
108.33
FCF Yield
1.94%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
90.03%
Operating Margin
8.53%
Net Margin
0.19%
Return on Equity (ROE)
4.05%
Return on Assets (ROA)
0.23%
Asset Turnover
1.21x
Revenue 3-Yr CAGR
38.33%
Financial Health & Liquidity
Current Ratio
7.25
Cash Ratio
3.35
Debt / Equity
16.096
Debt / Assets
0.917
Cash & Equivalents
$111.04M
Total Debt
$220.34M
Book Value / Share
$0.08
Cash Flow Efficiency
Operating Cash Flow
$28.63M
Capital Expenditures (CapEx)
$696.00K
Free Cash Flow
$27.93M
OCF / Revenue
9.81%
FCF / Revenue
9.57%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$0.08
EPS YoY Growth
100.00%
Balance Sheet (FY 2025)
Total Assets
$240.31M
Total Liabilities
$33.16M
Stockholders' Equity
$13.69M
Current Assets
$240.31M
Current Liabilities
$33.16M